You just read:

Medicenna to Present Latest Data from the MDNA55 Clinical Trial in Recurrent Glioblastoma at the Targeting Innate Immunity Congress

News provided by

Medicenna Therapeutics Corp.

Sep 12, 2019, 07:00 ET